Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2011

01.01.2011 | Original Article

The Role of Oral Hygiene in Inflammatory Bowel Disease

verfasst von: Shashideep Singhal, Delia Dian, Ali Keshavarzian, Louis Fogg, Jeremy Z. Fields, Ashkan Farhadi

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

The ‘hygiene hypothesis’ suggests that a reduction in the microbial exposure due to improved health measures has contributed to an immunological imbalance in the intestine and increased the incidence of autoimmune diseases such as inflammatory bowel diseases (IBD). Accordingly, we investigated associations between oral hygiene practices and IBD.

Methods

We developed and administered a multiple choice questionnaire to evaluate oral hygiene and dental care practices of 137 subjects (83 with IBD and 54 healthy controls).

Results

Of the 83 IBD cases, 31% had ulcerative colitis and 69% had Crohn’s disease. For subjects with IBD, the frequency of brushing at disease onset was significantly higher than in controls (P = 0.005). Also, the frequency of use of dental floss and breath freshener at disease onset was significantly higher in IBD patients (P = 0.005 and <0.001, respectively). Also, patients with IBD more frequently visited their dentist at disease onset (P < 0.001) and continued to visit their dentist more often (P < 0.001). IBD cases had a higher frequency of dental complications such as tooth caries (P = 0.007), oral ulcers (P = 0.04) and dry mouth (P = 0.001).

Conclusions

These findings suggest that oral hygiene practices may cause alterations in the flora of the oral mucosa, which causes imbalance in the gut microbiome (dysbiosis), and thereby contributes to the pathogenesis of IBD. Conversely, the increased frequency of dental problems in IBD patients might be due, at least in part, to alterations in oral flora or to their disease.
Literatur
1.
Zurück zum Zitat Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004;12(12):562–568.CrossRefPubMed Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 2004;12(12):562–568.CrossRefPubMed
2.
Zurück zum Zitat Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005;206:260–276.CrossRefPubMed Elson CO, Cong Y, McCracken VJ, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev. 2005;206:260–276.CrossRefPubMed
3.
Zurück zum Zitat Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11–18.CrossRefPubMed Seksik P, Sokol H, Lepage P, et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11–18.CrossRefPubMed
4.
Zurück zum Zitat Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1–4.CrossRefPubMed Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53(1):1–4.CrossRefPubMed
5.
Zurück zum Zitat Rochet V, Rigottier-Gois L, Sutren M, et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr. 2006;95(2):421–429.CrossRefPubMed Rochet V, Rigottier-Gois L, Sutren M, et al. Effects of orally administered Lactobacillus casei DN-114 001 on the composition or activities of the dominant faecal microbiota in healthy humans. Br J Nutr. 2006;95(2):421–429.CrossRefPubMed
6.
Zurück zum Zitat Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn’s disease. Lancet. 1990;336(8723):1096–1097.CrossRefPubMed Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn’s disease. Lancet. 1990;336(8723):1096–1097.CrossRefPubMed
7.
Zurück zum Zitat Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39(4 Suppl 2):S59–S65.CrossRefPubMed Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39(4 Suppl 2):S59–S65.CrossRefPubMed
9.
Zurück zum Zitat Maukonen J, Mättö J, Suihko ML, et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol. 2008;57(Pt 12):1560–1568.CrossRefPubMed Maukonen J, Mättö J, Suihko ML, et al. Intra-individual diversity and similarity of salivary and faecal microbiota. J Med Microbiol. 2008;57(Pt 12):1560–1568.CrossRefPubMed
10.
Zurück zum Zitat Kalliomäki M, Salminen S, Isolauri E. Positive interactions with the microbiota: probiotics. Adv Exp Med Biol. 2008;635:57–66.CrossRefPubMed Kalliomäki M, Salminen S, Isolauri E. Positive interactions with the microbiota: probiotics. Adv Exp Med Biol. 2008;635:57–66.CrossRefPubMed
11.
Zurück zum Zitat Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–1189. Sokol H, Seksik P, Furet JP, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–1189.
12.
Zurück zum Zitat Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105(43):16731–16736.CrossRefPubMed Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105(43):16731–16736.CrossRefPubMed
13.
Zurück zum Zitat Attin T, Hornecker E. Tooth brushing and oral health: how frequently and when should tooth brushing be performed? Oral Health Prev Dent. 2005;3(3):135–140.PubMed Attin T, Hornecker E. Tooth brushing and oral health: how frequently and when should tooth brushing be performed? Oral Health Prev Dent. 2005;3(3):135–140.PubMed
14.
Zurück zum Zitat Katz J, Shenkman A, Stavropoulos F, et al. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9(1):34–40.CrossRefPubMed Katz J, Shenkman A, Stavropoulos F, et al. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. Oral Dis. 2003;9(1):34–40.CrossRefPubMed
15.
Zurück zum Zitat Snyder MB, Cawson RA. Oral changes in Crohn’s disease. J Oral Surg. 1976;34(7):594–599.PubMed Snyder MB, Cawson RA. Oral changes in Crohn’s disease. J Oral Surg. 1976;34(7):594–599.PubMed
16.
Zurück zum Zitat Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn’s disease. Clin Gastroenterol Hepatol. 2005;3(9):886–891.CrossRefPubMed Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn’s disease. Clin Gastroenterol Hepatol. 2005;3(9):886–891.CrossRefPubMed
17.
Zurück zum Zitat Grössner-Schreiber B, Fetter T, Hedderich J, et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33(7):478–484.CrossRefPubMed Grössner-Schreiber B, Fetter T, Hedderich J, et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. J Clin Periodontol. 2006;33(7):478–484.CrossRefPubMed
18.
Zurück zum Zitat Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn’s disease and ulcerative colitis. J Clin Periodontol. 2008;35(6):555–560.CrossRefPubMed Brito F, de Barros FC, Zaltman C, et al. Prevalence of periodontitis and DMFT index in patients with Crohn’s disease and ulcerative colitis. J Clin Periodontol. 2008;35(6):555–560.CrossRefPubMed
19.
Zurück zum Zitat Van Dyke TE, Dowell VR Jr, Offenbacher S, et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun. 1986;53(3):671–677.PubMed Van Dyke TE, Dowell VR Jr, Offenbacher S, et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease. Infect Immun. 1986;53(3):671–677.PubMed
20.
Zurück zum Zitat Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7(1):47–51.PubMed Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7(1):47–51.PubMed
21.
Zurück zum Zitat Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165–173.CrossRefPubMed Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14(2):165–173.CrossRefPubMed
Metadaten
Titel
The Role of Oral Hygiene in Inflammatory Bowel Disease
verfasst von
Shashideep Singhal
Delia Dian
Ali Keshavarzian
Louis Fogg
Jeremy Z. Fields
Ashkan Farhadi
Publikationsdatum
01.01.2011
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1263-9

Weitere Artikel der Ausgabe 1/2011

Digestive Diseases and Sciences 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.